Archive

Archive for the ‘Opinion’ Category

Pluristem (PSTI) the barn door opened and the horses bolted

November 9th, 2012 No comments

Did PSTI avoid the issues of disclosure having “played loose and fast” with public perception? Read more…

Categories: Opinion, Pluristem (PSTI)

Just when we thought it was over-ambiguity pops it head-Still a legality challenge of hESC federal funding

October 18th, 2012 No comments

       Sherley vs Sebelius’, hESC suit kicked to Supreme Court … Read more…

International Stem Cell Corporation (OTC: ISCO) Key patent or …?

September 25th, 2012 No comments

      Cell and tissue therapy,   “My a__” Read more…

Neuralstem Inc. (CUR) Jumping the Gun or Fast and Furious … Sell!

September 14th, 2012 No comments

    SEC gun-jumping and quiet period restrictions? Read more…

NeoStem (NYSE MKT: NBS) No monetary offering, filings tidy up the books and the cap structure

August 27th, 2012 No comments

    Facts versus fiction Read more…

Geron (GERN) 10 Facts that justify a 10% near term BUY

August 1st, 2012 No comments

    So am I smoking weed or sowing seeds? Read more…

Categories: Geron (GERN), Opinion

Bankrolling the enemy and Hostage taking – Selling Short

July 17th, 2012 No comments

 What should be criticized … Read more…

Fort Myers doctor reaching settlement with state in stem cell patient’s death

July 10th, 2012 No comments

A Fort Myers physician whose license was restricted for his involvement in a controversial stem cell treatment on a patient who died has a settlement in the works with state regulators. Read more…

IntelliCell (OTC QB:SVFC) Updating: FDA Warning Letter

March 28th, 2012 No comments

SVFC had received a warning letter, dated 3/13/12, from the FDA related to an inspection of SVFC conducted between 11/8 - 12/12/11.

Read more…

Opinion: Post Silicone Scandal: Stem Cell enriched Autologous Breast Augmentation a Safer Alternative

January 10th, 2012 No comments

Stem cell-enriched autologous fat enables … sustainable … breast augmentation Read more…